François Clément Bidard, Romain-David Seban, Stephanie M. van de Ven, Sylvain Ladoire, Jean-Louis Alberini, Audrey Bellesoeur, Sandrine Parisse-Di Martino, Olivier Humbert, Thibaut Cassou Mounat, Emmanuel Deshayes, Loic Djaileb, Khaldoun Kerrou, Elise Deluche, Alexandre Cochet. "[
                    <sup>18</sup>
                    F] Fluoroestradiol PET/CT to guide second-line treatment decision-making in patients with estrogen receptor–positive, HER2-negative advanced breast cancer after progression on first-line aromatase inhibitor and CDK4/6 inhibitor: Primary results of ESTROTIMP.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.1077